Inventor · disambiguated record
Xiao-Ling Fan Cockcroft
Also filed as: COCKCROFT XIAO-LING · COCKCROFT XIAO-LING F · COCKCROFT XIAO-LING FAN
22 granted patents·11 pending applications·367 citations·filing 2000–2021
96Inventor score
Files withKUDOS PHARM LTD23CANCER REC TECH LTD2MAYBRIDGE LTD2BOEHRINGER INGELHEIM INT1COCKCROFT XIAO LING FAN1
Top patents by PatentIndex Score
33 records- 0197US7449464B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2004·Granted Nov 11, 2008·69 cites·2 claims
- 0295US7662818B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2005·Granted Feb 16, 2010·20 cites·7 claims
- 0394US6589950B1Purine derivatives inhibitors of tyrosine protein kinase SYKNOVARTIS AG·Filed 2000·Granted Jul 8, 2003·106 cites·12 claims
- 0491US7981889B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2008·Granted Jul 19, 2011·17 cites·9 claims
- 0591US7504397B2mTOR inhibitor compoundsKUDOS PHARM LTD·Filed 2006·Granted Mar 17, 2009·12 cites·14 claims
- 0689US11319318B2Pyridinones and isoquinolinones as inhibitors of the bromodomain BRD9BOEHRINGER INGELHEIM INT·Filed 2016·Granted May 3, 2022·6 cites·6 claims
- 0788US7407957B2Phthalazinone derivativesMAYBRIDGE LTD·Filed 2005·Granted Aug 5, 2008·22 cites·12 claims
- 0887US9566276B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2015·Granted Feb 14, 2017·4 cites·12 claims
- 0987US7470688B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2006·Granted Dec 30, 2008·10 cites·14 claims
- 1086US9169235B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2014·Granted Oct 27, 2015·5 cites·12 claims
- 1185US8912187B2Phthalazinone derivativesMARTIN NIALL MORRISON BARR·Filed 2011·Granted Dec 16, 2014·9 cites·12 claims
- 1285US7196085B2Phthalazinone derivativesMAYBRIDGE PLC·Filed 2003·Granted Mar 27, 2007·43 cites·29 claims
- 1385US7049313B2ATM inhibitorsKUDOS PHARM LTD·Filed 2003·Granted May 23, 2006·19 cites·9 claims
- 1484US10449192B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2018·Granted Oct 22, 2019·2 cites·4 claims
- 1583US7666870B2Phthalazinone derivativesMAYBRIDGE LTD·Filed 2008·Granted Feb 23, 2010·7 cites·5 claims
- 1682US7674823B2DNA-PK inhibitorsCANCER REC TECH LTD·Filed 2007·Granted Mar 9, 2010·3 cites·7 claims
- 1779US11160803B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2019·Granted Nov 2, 2021·0 cites·9 claims
- 1877US7696203B2DNA-PK inhibitorsKUDOS PHARM LTD·Filed 2006·Granted Apr 13, 2010·4 cites·9 claims
- 1971US7226918B2DNA-PK inhibitorsCANCER REC TECH LTD·Filed 2002·Granted Jun 5, 2007·4 cites·9 claims
- 2070US7429660B2ATM inhibitorsKUDOS PHARM LTD·Filed 2004·Granted Sep 30, 2008·4 cites·12 claims
- 2162US2017226124A1Phthalazinone derivativesKUDOS PHARM LTD·Filed 2017·Application pending·0 cites
- 2261US10085986B2Pyrimidinone compounds and their useCOCKCROFT XIAO LING FAN·Filed 2012·Granted Oct 2, 2018·1 cites·12 claims
- 2360US7902193B2Phthalazinone derivativesKUDOS PHARM LTD·Filed 2008·Granted Mar 8, 2011·0 cites·14 claims
- 2458US2009043091A1Atm inhibitorsKUDOS PHARM LTD·Filed 2008·Application pending·0 cites
- 2558US2023015617A1Phthalazinone derivativesKUDOS PHARM LTD·Filed 2021·Application pending·0 cites
- 2647US2007049588A1Atm inhibitorKUDOS PHARM LTD·Filed 2006·Application pending·0 cites
- 2746US2009181951A1Parp inhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 2846US2009281086A12 -oxyheteroarylamide derivatives as parp inhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 2946US2009209520A12 -oxybenzamide derivatives as parp inhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 3045US2008194546A1Pyrido-, Pyrazo- and Pyrimido-Pyrimidine Derivatives as mTOR InhibitorsKUDOS PHARM LTD·Filed 2007·Application pending·0 cites
- 3143US2010130473A1CompoundsHUMMERSONE MARC GEOFFREY·Filed 2006·Application pending·0 cites
- 3243US2006199803A1CompoundsKUDOS PHARM LTD·Filed 2006·Application pending·0 cites
- 3343US2006135770A1PARP inhibitorsKUDOS PHARM LTD·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xiao-Ling Fan Cockcroft files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →